{{Rsnum
|rsid=167428
|Gene=FGF2
|Chromosome=4
|position=122852284
|Orientation=plus
|GMAF=0.3751
|Gene_s=FGF2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 51.3 | 39.8
| HCB | 1.5 | 20.4 | 78.1
| JPT | 0.9 | 19.5 | 79.6
| YRI | 87.1 | 12.9 | 0.0
| ASW | 64.9 | 33.3 | 1.8
| CHB | 1.5 | 20.4 | 78.1
| CHD | 1.8 | 11.9 | 86.2
| GIH | 12.9 | 48.5 | 38.6
| LWK | 77.3 | 19.1 | 3.6
| MEX | 12.1 | 37.9 | 50.0
| MKK | 46.2 | 42.3 | 11.5
| TSI | 7.8 | 35.3 | 56.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=24146310
|Title=Genetic Variants in the Fibroblast Growth Factor Pathway as Potential Markers of Ovarian Cancer Risk, Therapeutic Response, and Clinical Outcome
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}